Videos

Professor Ed Zajac on renewing our research interests at the crossroads

Biography

Kellogg School of Management
James F. Bere Professor of Management & Organizations

Ed Zajac joined the faculty of the Kellogg School of Management after completing his Ph.D. in organization and strategy at the Wharton School, University of Pennsylvania. At Kellogg, he received the James F. Bere Chair and the Sidney J. Levy Teaching Award. He was a Fulbright Scholar at the University of Cologne and a visiting scholar at Erasmus University in Rotterdam, the Free University of Berlin, Hong Kong University of Science and Technology, the National University of Singapore, and the University of Zurich. He is an elected Fellow of both the Academy of Management and the Strategic Management Society, and the recipient of an honorary doctorate from the Free University of Berlin.

Professor Zajac's research, teaching, and consulting focuses on strategy, alliances, and corporate governance. His award-winning research has been published widely in major academic journals, such as the Strategic Management Journal, Administrative Science Quarterly, Organization Science, Academy of Management Journal, American Sociological Review, and the Proceedings of the National Academy of Arts and Sciences. He has repeatedly been recognized in the Institute of Scientific Information's yearly list of "most highly cited researchers" worldwide (representing less than one-half of one percent of all published researchers), and his published work has garnered over 20000 citations over his Kellogg career. His research contributions have also earned him the Distinguished Scholar Award from the Organization and Management Theory Division of the Academy of Management, as well as the Outstanding Scholar Award from the Western Academy of Management. He also served for many years as Co-Editor of the Strategic Management Journal.

Professor Zajac has developed a number of courses at Kellogg in his areas of expertise: Creating and Managing Strategic Alliances addresses the design and management of joint ventures, licensing agreements, consortia, and other structures for cooperation. Advanced Strategic Management examines how organizations can better adapt to changing environments by holistically addressing both strategy formulation and implementation challenges). Organizational Design focuses on the role of structure and systems in supporting an organization's strategy, and Corporate Governance analyzes the interdependent roles of the CEO, board of directors, shareholders and other stakeholders in the modern public corporation, both in the U.S. and abroad.

Professor Zajac is also active in executive education and consulting in North America, Europe, Asia, and Latin America in the areas of strategy formulation and implementation, strategic alliances, and corporate governance.  He has worked with organizations such as Abbott, AstraZeneca, Baxter, Blue Cross/Blue Shield (the Association, HCSC, and the Kansas, Michigan, Minnesota, Illinois, North Carolina, and North Dakota plans), Brady, Bristol-Meyers Squibb, Brunswick, Cargill, Caterpillar, Cigna, Commonwealth Edison, ConocoPhillips, Cooper Tire & Rubber, Copersucar, R.R. Donnelly, Edwards Lifesciences, FTI Ringtail, General Mills, W.W. Grainger, Harnischfeger, Hearst, Healthways, Hollister, Hu-Friedy, IBM, Idealease, the Institute for Corporate Directors (Canada), Johnson & Johnson, Land O'Lakes, Libbey, Eli Lilly, MARKEM, Merck, Monsanto, Novo Nordisk, Pfizer, Premier, Procter & Gamble, Public Service Company of New Mexico, O'Melveny & Myers, Rockwell Automation, Rockwell Collins, Sanofi-Aventis, Savoy Brands Internacional, Schering-Plough, Siemens, Topco, Toyota, Zurich Insurance, several U.S. governmental agencies, and numerous professional associations (particularly in health care).  He is currently a board member at Scot Forge (an ESOP company), and he formerly served as board chair at Pioneer Surgical Technology, and as a board member at PeopleFlo Manufacturing, Roberts Industries and The Wetlands Initiative.

Areas of Expertise Competitive Analysis
Corporate Governance
Organizational Structure and Relationships
Strategic Management and Implementation
Strategy

Education PhD, Organization and Strategy, University of Pennsylvania

Academic Positions Professor, Management & Organizations, Kellogg School of Management, Northwestern University, 1995-present

James F. Bere Distinguished Professor of Management and Organizations, Kellogg School of Management, Northwestern University, 1993-present

Professor, Sociology (by Courtesy), Weinberg College of Arts of Sciences, Northwestern University, 1995-present

Professor, Health Enterprise Management, Kellogg School of Management, Northwestern University, 1995-present

Associate Professor, Kellogg School of Management, Northwestern University, 1991-1995

Assistant Professor, Kellogg School of Management, Northwestern University, 1986-1991

Honors and Awards Best Paper Award, International Corporate Governance Society, 2016

Best Published Paper Award, Oxford University Center for Corporate Reputation, 2014

Outstanding Scholar Award, Western Academy of Management, 2015

Distinguished Scholar Award, Organization and Management Division of the Academy of Management, 2013

Honorary Doctorate from the School of Business and Economics, Free University of Berlin, 2012

Recognized as one of the "most highly cited researchers" worldwide in the Institute of Scientific Information's yearly list of highly cited researchers, Institute of Scientific Information, 2012

Editorial Positions Consulting Editor, Strategic Management Journal, 2013-Present

Co-Editor, Strategic Management Journal, 2007-2013

Editorial Board, Asia Pacific Journal of Management, 2015-2016

Education Academic Positions Honors and Awards Editorial Positions

Read about executive education

Cases

Loffler, Alicia, Markus Solf and Edward Zajac. 2004. Bayer & Millennium Pharmaceuticals. Case 5-104-014 (KEL068).

In the year 2000 Millennium Pharmaceuticals was the poster child for successful genomic companies. Millennium's fast growth and exuberant valuations were due to the elegant alliances the company had forged with top pharmaceutical, biotechnology, and agricultural companies. However as the market shifted and Millennium was forced to fully integrate, the type and structure of its alliances no longer worked. This case illustrates how strategic alliances are used in biotechnology as growth tools and demonstrates the impact that market conditions can have on the evolution of alliances.

Loffler, Alicia, Markus Solf and Edward Zajac. 2004. Bayer & Millennium Pharmaceuticals. Case 5-104-014 (KEL068).

In the year 2000 Millennium Pharmaceuticals was the poster child for successful genomic companies. Millennium's fast growth and exuberant valuations were due to the elegant alliances the company had forged with top pharmaceutical, biotechnology, and agricultural companies. However as the market shifted and Millennium was forced to fully integrate, the type and structure of its alliances no longer worked. This case illustrates how strategic alliances are used in biotechnology as growth tools and demonstrates the impact that market conditions can have on the evolution of alliances.

Other experts

Overview I am a Senior Clinical Lecturer and Honorary Respiratory Physician. I have a specialist interest in asthma and provide one asthma clinic at UHSM per week. I currently hold an Asthma UK Senior Clinical Academic Development Award (2014) to research the circadian biology of asthma. Biograph...
Peter is a PhD researcher, practitioner and consultant in innovation management strategies and a senior expert in business development and operations management. He is currently working on his PhD at the Department of Management and Organization and the European Institute of Japanese Studies at ...
BiographyResearch InterestTopics Entrepreneurship & Innovation Strategy & Organization Strategy Industries Consumer goods Health Care Pharmaceutical Industry Geographical area Europe USA